Partnering with Oncobiologics
Partnering is a critical element of the Oncobiologics growth strategy. To date, the company has engaged with leading pharmaceutical and biotechnology companies to explore the joint advancement of our our biosimilar programs, while retaining significant value in the downstream potential of our partnered programs.
The company is actively exploring alliances that complement our expertise in biologics product development with important scientific, clinical and business capabilities. These alliances may incorporate our technology platforms, product candidates and biologic product development capabilities.
Oncobiologics offers prospective partners an efficient due-diligence process, including remote access to data-room to review confidential materials.
To inquire regarding partnership opportunities with Oncobiologics, please contact:
Stephen J. McAndrew, Ph.D.
Senior Vice President, Business Strategy & Development
609-619-3990 ext. 216